Sign Out
Symptoms: Inhalation or oral administration of excessive doses of corticosteroids may lead to suppression of HPA axis function.
Management: Because the systemic bioavailability of MONASAL NASAL SPRAY is <1%, overdose is unlikely to require any therapy other than observation, followed by initiation of the appropriate prescribed dosage.
Continue with Google